Christoph Melzer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Christoph Melzer has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
Gert Baumann
The Medical Division , Charité University Medical Centre , Berlin , Germany
5 shared publications- Gert Baumann
Medizinische Klinik für Kardiologie und Angiologie, Campus Mitte, Charité - Universitätsmedizin Berlin, Germany
5 shared publications - Adrian Constantin Borges
Medizinische Klinik für Kardiologie und Angiologie, Campus Mitte, Charité - Universitätsmedizin Berlin, Germany
4 shared publications H. Theres
Charité-Campus Mitte, Medizinische Klinik mit Schwerpunkt Kardiologie Angiologie, Pneumologie, Schumannstrasse 20/21, D-10117 Berlin Germany
4 shared publicationsHeinz Theres
Medizinische Klinik Charité, Berlin, Germany
4 shared publications- Henryk Dreger
DZHK (German Centre for Cardiovascular Research), partner site Berlin
4 shared publications
Latest Publications
- Open Access
- 4 December 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e63391
Telemonitoring for Chronic Heart Failure: Narrative Review of the 20-Year Journey From Concept to Standard Care in Germany
Background: Chronic heart failure (CHF) is a major cause of morbidity and mortality worldwide, placing a significant burden on health care systems. The concept of telemedicine for CHF was first introduced in the late 1990s, and since 2010, studies have demonstrated its potential to improve patient outcomes and reduce health care costs. Over the following decade, technological advancements and changes in health care policy led to the development of more sophisticated telemedicine solutions for CHF, including remote patient management through invasive or noninvasive telemonitoring devices, mobile apps, and virtual consultations. Years of public funding in Germany have generated evidence that remote patient management improves outcomes for patients with CHF, such as quality of life, and reduces hospital admissions. Based on these data, the Federal Joint Committee (Gemeinsamer Bundesausschuss; G-BA) decided, independently of the current European Society of Cardiology recommendations, to incorporate telemedicine as a standard digital intervention for high-risk patients with reduced left ventricular ejection fraction in Germany in 2020. Objective: This review aims to illustrate the journey from the initial concept through pioneering studies that led to telemedicine’s integration into standard care, and to share current experiences that have positioned Germany as a leader in cardiovascular telemedicine. Methods: We review and discuss existing literature and evidence on the development and implementation of telemonitoring for CHF in Germany over the past 20 years. Relevant studies, reports, and guidelines were identified through a comprehensive search of electronic databases, including PubMed, Google Scholar, and specialized journals focused on CHF telemonitoring. Results: Pioneering studies, such as the TIM-HF2 (Telemedical Interventional Management in Heart Failure II) and IN-TIME (Influence of Home Monitoring on Mortality and Morbidity in Heart Failure Patients with Impaired Left Ventricular Function) trials, demonstrated the effectiveness of remote patient management applications for patients with CHF in Germany and their applicability to current practices involving both invasive and noninvasive methods. Collaborations between researchers and technology developers overcame barriers, leading to sustainable improvements in patient care. Ongoing research on artificial intelligence applications for prioritizing and interpreting individual health data will continue to transform digital health care. Conclusions: The establishment of telemedical care for patients with HF across Europe is likely to benefit from experiences in Germany, where significant improvements have been achieved in the care of patients with HF.
- 4 December 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e63391
Open AccessTelemonitoring for Chronic Heart Failure: Narrative Review of the 20-Year Journey From Concept to Standard Care in Germany
Background: Chronic heart failure (CHF) is a major cause of morbidity and mortality worldwide, placing a significant burden on health care systems. The concept of telemedicine for CHF was first introduced in the late 1990s, and since 2010, studies have demonstrated its potential to improve patient outcomes and reduce health care costs. Over the following decade, technological advancements and changes in health care policy led to the development of more sophisticated telemedicine solutions for CHF, including remote patient management through invasive or noninvasive telemonitoring devices, mobile apps, and virtual consultations. Years of public funding in Germany have generated evidence that remote patient management improves outcomes for patients with CHF, such as quality of life, and reduces hospital admissions. Based on these data, the Federal Joint Committee (Gemeinsamer Bundesausschuss; G-BA) decided, independently of the current European Society of Cardiology recommendations, to incorporate telemedicine as a standard digital intervention for high-risk patients with reduced left ventricular ejection fraction in Germany in 2020. Objective: This review aims to illustrate the journey from the initial concept through pioneering studies that led to telemedicine’s integration into standard care, and to share current experiences that have positioned Germany as a leader in cardiovascular telemedicine. Methods: We review and discuss existing literature and evidence on the development and implementation of telemonitoring for CHF in Germany over the past 20 years. Relevant studies, reports, and guidelines were identified through a comprehensive search of electronic databases, including PubMed, Google Scholar, and specialized journals focused on CHF telemonitoring. Results: Pioneering studies, such as the TIM-HF2 (Telemedical Interventional Management in Heart Failure II) and IN-TIME (Influence of Home Monitoring on Mortality and Morbidity in Heart Failure Patients with Impaired Left Ventricular Function) trials, demonstrated the effectiveness of remote patient management applications for patients with CHF in Germany and their applicability to current practices involving both invasive and noninvasive methods. Collaborations between researchers and technology developers overcame barriers, leading to sustainable improvements in patient care. Ongoing research on artificial intelligence applications for prioritizing and interpreting individual health data will continue to transform digital health care. Conclusions: The establishment of telemedical care for patients with HF across Europe is likely to benefit from experiences in Germany, where significant improvements have been achieved in the care of patients with HF.
- 21 April 2023
- Published by Elsevier in International Journal of Cardiology
- Vol. 384, 37
Reply to “CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy”
- 21 April 2023
- Published by Elsevier in International Journal of Cardiology
- Vol. 384, 37
Reply to “CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy”
- 2 February 2023
- Published by Elsevier in International Journal of Cardiology
- Vol. 377, 60-65
Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic – Results of a prospective registry
- 2 February 2023
- Published by Elsevier in International Journal of Cardiology
- Vol. 377, 60-65
Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic – Results of a prospective registry
- 4 August 2021
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 23 (9) , 1333
In Memoriam Prof. Dr sc. med. Joachim Witte (1936–2021)
- 4 August 2021
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 23 (9) , 1333
In Memoriam Prof. Dr sc. med. Joachim Witte (1936–2021)
- 14 April 2011
- Vol. 52 (4) , 587-91
Fast-track pulmonary conditioning before urgent cardiac surgery in patients with insufficiently treated chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is an important risk factor for perioperative morbidity and mortality in patients undergoing cardiac surgery. Despite high clinical relevance, current guidelines lack clear recommendations on the optimal approach for patients with insufficiently treated COPD and urgent need for cardiac surgery. The aim of the present study was to analyze the efficacy of short-term pulmonary conditioning (PC) in this subset of cardiopulmonary patients. Eighteen patients with urgent need for cardiac surgery were treated with 1 mg budenoside twice a day, 1.25 mg salbutamol four times a day and 15 mg ambroxol three times a day. On average, patients received pulmonary conditioning for 5.1 ± 2.1 days. Lung function was assessed before and after treatment. Pulmonary conditioning improved forced expiratory volume in one second (FEV1) by 16% (P<0.001). Predicted FEV1 increased from 48.3 ± 13.6% at baseline to 55.4 ± 16.1% after treatment (P<0.001). Total resistance was reduced from 0.933 ± 0.418 kPa·s/L to 0.631 ± 0.344 kPa·s/L after PC (P=0.004). The percentage of patients in GOLD stages III-IV was reduced from 55.6% at baseline to 27.8% after treatment. After surgery, patients needed mechanical ventilation for 2 ± 3.4 days. One patient (5.6%) received a tracheostomy and four patients (22.2%) developed pneumonia; 30-day mortality was 5.6%. Short-term treatment with budenoside, salbutamol and ambroxol significantly improved lung function parameters. If surgery can be delayed for several days, pulmonary conditioning should be considered for patients with insufficiently treated COPD.
- 14 April 2011
- Vol. 52 (4) , 587-91
Fast-track pulmonary conditioning before urgent cardiac surgery in patients with insufficiently treated chronic obstructive pulmonary disease.
Chronic obstructive pulmonary disease (COPD) is an important risk factor for perioperative morbidity and mortality in patients undergoing cardiac surgery. Despite high clinical relevance, current guidelines lack clear recommendations on the optimal approach for patients with insufficiently treated COPD and urgent need for cardiac surgery. The aim of the present study was to analyze the efficacy of short-term pulmonary conditioning (PC) in this subset of cardiopulmonary patients. Eighteen patients with urgent need for cardiac surgery were treated with 1 mg budenoside twice a day, 1.25 mg salbutamol four times a day and 15 mg ambroxol three times a day. On average, patients received pulmonary conditioning for 5.1 ± 2.1 days. Lung function was assessed before and after treatment. Pulmonary conditioning improved forced expiratory volume in one second (FEV1) by 16% (P<0.001). Predicted FEV1 increased from 48.3 ± 13.6% at baseline to 55.4 ± 16.1% after treatment (P<0.001). Total resistance was reduced from 0.933 ± 0.418 kPa·s/L to 0.631 ± 0.344 kPa·s/L after PC (P=0.004). The percentage of patients in GOLD stages III-IV was reduced from 55.6% at baseline to 27.8% after treatment. After surgery, patients needed mechanical ventilation for 2 ± 3.4 days. One patient (5.6%) received a tracheostomy and four patients (22.2%) developed pneumonia; 30-day mortality was 5.6%. Short-term treatment with budenoside, salbutamol and ambroxol significantly improved lung function parameters. If surgery can be delayed for several days, pulmonary conditioning should be considered for patients with insufficiently treated COPD.
- Open Access
- 1 September 2010
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 8 (1) , 35
Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
- 1 September 2010
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 8 (1) , 35
Open AccessSuccessful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy
- Open Access
- 13 February 2010
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (4) , 464-465
Chronotropic incompetence: a never-ending story
This editorial refers to ‘Chronotropic incompetence and autonomic dysfunction in patients without structural heart disease’ by T. Kawasaki et al ., on page 561.
- 13 February 2010
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (4) , 464-465
Open AccessChronotropic incompetence: a never-ending story
This editorial refers to ‘Chronotropic incompetence and autonomic dysfunction in patients without structural heart disease’ by T. Kawasaki et al ., on page 561.
- Open Access
- 25 September 2009
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 46
A modified echocardiographic protocol with intrinsic plausibility control to determine intraventricular asynchrony based on TDI and TSI
Established methods to determine asynchrony suffer from high intra- and interobserver variability and failed to improve patient selection for cardiac resynchronization therapy (CRT). Thus, there is a need for easy and robust approaches to reliably assess cardiac asynchrony.
- 25 September 2009
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 46
Open AccessA modified echocardiographic protocol with intrinsic plausibility control to determine intraventricular asynchrony based on TDI and TSI
Established methods to determine asynchrony suffer from high intra- and interobserver variability and failed to improve patient selection for cardiac resynchronization therapy (CRT). Thus, there is a need for easy and robust approaches to reliably assess cardiac asynchrony.
- Open Access
- 25 November 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 58
Implementation of seven echocardiographic parameters of myocardial asynchrony to improve the long-term response rate of cardiac resynchronization therapy (CRT)
Cardiac resynchronization Therapy (CRT) is an effective therapy for chronic heart failure with beneficial hemodynamic effects leading to a reduction of morbidity and mortality. The responder rates, however, are low. There are various and contentious echocardiographic parameters of myocardial asynchrony. Patient selection by echocardiographic assessment of asynchrony is thought to improve responder rates.
- 25 November 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 58
Open AccessImplementation of seven echocardiographic parameters of myocardial asynchrony to improve the long-term response rate of cardiac resynchronization therapy (CRT)
Cardiac resynchronization Therapy (CRT) is an effective therapy for chronic heart failure with beneficial hemodynamic effects leading to a reduction of morbidity and mortality. The responder rates, however, are low. There are various and contentious echocardiographic parameters of myocardial asynchrony. Patient selection by echocardiographic assessment of asynchrony is thought to improve responder rates.
- Open Access
- 16 January 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 4
Interventricular septum hematoma during cineventriculography
Intraseptal hematoma and subsequent myocardial infarction due to accidental contrast agent deposition complicating diagnostic cineventriculography is a previously undescribed complication of angiography.
- 16 January 2008
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 6 (1) , 4
Open AccessInterventricular septum hematoma during cineventriculography
Intraseptal hematoma and subsequent myocardial infarction due to accidental contrast agent deposition complicating diagnostic cineventriculography is a previously undescribed complication of angiography.